Pharmafile Logo
Pharmafocus logo
Advanced Search
laree2

What can previous outbreak modeling tell us about the COVID-19 pandemic?

May 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Interview, coronavirus, feature, pharma

Dr LaRee Tracy, a lecturer at San Diego State University and Director of Biostatistics at PHASTAR, led a team of …

Feature
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous Entyvio approved in Europe for maintenance of moderate to severe Crohn’s and ulcerative colitis

May 11, 2020
Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, ulcerative colitis

The European Commission has awarded marketing approval to Takeda’s subcutaneous formulation of its gut-selective biologic therapy Entyvio (vedolizumab) as a …

News
nhs_doctors

Latest large hydroxychloroquine study suggests it does not help treat COVID-19

May 11, 2020
Sales and Marketing COVID-91, coronavirus, hydroxychloroquine

The results of another study into the use of hydroxychloroquine in COVID-19 patients has cast further doubts on its effectiveness …

News
fda2outsideweb

Lynparza combo authorised in US for first-line maintenance of HRD-positive advanced ovarian cancer

May 11, 2020
Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer

Lynparza (olaparib), developed by AstraZeneca and MSD, has secured FDA approval when paired with bevacizumab as a first-line maintenance treatment …

News
fda

Eli Lilly’s Retevmo approved by FDA to treat lung and thyroid cancers

May 11, 2020
Sales and Marketing COVID-19, coronavirus

The FDA has announced that Retevmo (selpercatinib) has been approved to treat both non-small-cell lung cancer (NSCLC) and medullary thyroid …

News
trial

NIAID announces the launch of second remdesivir trial for COVID-19 patients

May 11, 2020
Sales and Marketing COVID-19, coronavirus, niaid, remdesivier

The US National Institute of Allergy and Infectious Diseases (NAID) has announced that it is enrolling COVID-19 patients in hospital …

News

NICE gives thumbs-up to Roche’s Kadcyla in HER2+ breast cancer sub-population

May 7, 2020
Sales and Marketing Cancer, Kadcyla, NHS, NICE, Roche, UK, breast cancer

NICE has revealed that it has recommended the NHS use of Roche’s Kadcyla (trastuzumab emtansine) for HER2+ breast cancer in …

News
coronavirus_sars-cov-2

Black people are four times more likely to die from COVID-19 than white in England and Wales, ONS report shows

May 7, 2020
Business Services COVID-19, coronavirus

A recent report from the Office of National Statistics has shown that black people in England and Wales are four …

News

FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14

May 7, 2020
Sales and Marketing Incyte, Novartis, Tabrecta, pharma

The FDA has awarded marketing authorisation to Novartis for the Oral MET inhibitor Tabrecta (capmatinib) for the first-line treatment of metastatic non-small …

News
boris

UK becomes first European country to pass 30,000 deaths from COVID-19

May 7, 2020
Business Services COVID-19, coronavirus

Britain has become the first European nation to pass 30,000 deaths from the coronavirus, putting it only behind the US as …

News
cdc_coronavirus

Scientists in the UK and US identify hundreds of mutations in the COVID-19 virus

May 7, 2020
Business Services COVID-19, Protein, coronavirus, virus

Two studies from the UK and US have identified hundreds of mutations in COVID-19, which could cause problems for the …

News
korea_govt

South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients

May 6, 2020
Research and Development COVID-19, coronavirus, south korea

South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …

News
fda2outsideweb

AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction

May 6, 2020
Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure

The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …

News
partnership

Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal

May 6, 2020
Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma

Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …

News
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 6, 2020
Research and Development COVID-19, coronavirus

Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal “positive” data for Gilead’s remdesivir in …

News
trumpppppp

Ousted chief of BARDA says Trump administration ignored COVID-19 warnings

May 6, 2020
Research and Development BARDA, COVID-19, chloroquine, coronavirus, hydroxychloroquine

Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …

News
jonathanfreve

Jonathan Freve joins Galecto as Chief Financial Officer

May 5, 2020
Manufacturing and Production

The biotech company Galecto Inc have appointed Jonathan Freve as its Chief Financial Officer, and in his role he will …

Appointment
france-3370174_1280

First French case of COVID-19 occurred in December, a month earlier than previously thought

May 5, 2020
Manufacturing and Production COVID-19, coronavirus

A French patient who suffered from pneumonia in December actually had COVID-19, it has been revealed. Dr Yves Cohen, the …

News
Malaria treatment in Angola

Scientists in Kenya discover microbe that could stop transmission of malaria

May 5, 2020
Manufacturing and Production malaria, mosquitoes

Researchers studying malaria in Kenya have discovered a microbe that blocks transmission of malaria from mosquitoes which could pave the …

News
s300_yellow-card-govuk960

MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments

May 5, 2020
Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma

A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026